11th international SCWD conference on cachexia, sarcopenia and muscle wasting


Dates : 7-9 December 2018
Maastricht Netherlands
Official Language: English


‘Basic Science’ and ‘Clinical Science’ tracks:

  • Cachexia in Cancer, Heart Failure, COPD, CKD and Stroke
  • Sarcopenia, Frailty and the Dysmobility Syndrome
  • Pathophysiology and Epidemiology of Muscle Wasting
  • Body Composition Assessments
  • Screening, Diagnostic and Management
  • Special Populations
  • Clinical Trial Data

Registration prices

  • Medical professionals • 790.00 € (650.00 € until 25 Sept. 2018)
  • Nurses, technicians and doctors <35 years of age • 590.00 € (490.00 € until 25 Sept. 2018)
  • Abstract presenters • 490.00 €
  • Abstract presenters (industry) • 790.00 €
  • Industry representatives • 1 650.00 € (1 250.00 € until 25 Sept. 2018)

Click here for conference registration.

Venue and Hotel

Hotel Crown Plaza Maastricht

Ruiterij 1

6221 EW Maastricht

The Netherlands


Conference sponsors



Dear Colleague,

The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) is pleased to invite you to attend its first Updates Programme on Cachexia, Sarcopenia and Wasting Diseases that will be held on December 7-9, 2018, in Maastricht Netherlands.

As an international and multidisciplinary organization, the SCWD seeks to further research on cachexia, sarcopenia and muscle wasting in order to bring practical solutions to healthcare teams worldwide.

Since the first cachexia conference that took place in Berlin in 2000, over 2000 physicians from over 25 countries have attended our educational sessions.

In 2015, 60 international speakers and over 500 participants joined together in Paris. They expressed the need to hold a conference annually. That is the reason why the Board of SCWD organised a rich two-day program in Berlin on December 6-8, 2016 which gathered over 300 participants.

We expect this SCWD updates 2017 to be a unique forum for all medical professionals dealing with muscle wasting in their disciplines and we look forward to meeting you in Rome.

Yours sincerely,

John E. Morley      Stefan D. Anker

International Scientific Committee

Stefan D. Anker (President) – Berlin, Germany
John E. Morley – St. Louis, USA
William J. Evans – Durham, USA
Akio Inui – Kobe, Japan
Josep M. Argiles – Barcelona, Spain
Filippo Rossi-Fanelli – Rome, Italy
Vickie E. Baracos – Edmonton, Canada
Andrew Coats – Melbourne, Australia and Warwick, UK
Wolfram Doehner – Berlin, Germany
Luigi Ferrucci – Baltimore, USA
David J. Glass – Cambridge, USA
Aminah Jatoi – Rochester, USA
Kamyar Kalantar-Zadeh – Torrance, USA
Florian Strasser – St. Gallen, Switzerland
Stephan von Haehling – Göttingen, Germany


Overview on wasting disorders

SCWD articles based on the literature:
Cachexia >
Sarcopenia >
Muscle wasting >

Abstract submission

Late breaking abstract submission deadline: 30 September 2018 
Late-breaking research and clinical abstract deadline: 30 September 2018 
Abstract submission>


Educational Objectives

Following this activity, the audience will be able to: 
1. Review the latest information about the pathophysiology of muscle wasting and its epidemiology.
2. Screen for and diagnose cachexia, sarcopenia, frailty and dysmobility resulting from the following diseases or chronic conditions: cancer, cardiovascular disease, COPD, CKD, dementia/Alzheimer’s disease, diabetes, infectious diseases, stroke and aging.
3. Develop appropriate management programs for patients across the continuum of care.


Target Audience

Internists, oncologists, cardiologists, gerontologists, palliative care specialists, primary care physicians and nurses.